EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program
September 28, 2021 08:00 ET | EDAP TMS S.A.
Brings advanced focal ablation to prostate cancer patients in the Pacific Northwest LYON, France, September 28, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
flurotest.png
FluroTest Provides System Development Update; Reports Saliva-based Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional
September 16, 2021 08:00 ET | FluroTech Ltd.
CALGARY, Alberta, Sept. 16, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Presentation of Multiple Abstracts Favorably Comparing HIFU to Surgery at the American Urological Association 2021 Annual Meeting
September 14, 2021 08:00 ET | EDAP TMS S.A.
Data demonstrate superiority of HIFU versus radical prostatectomy among prostate cancer patients LYON, France, September 14, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Participate at Upcoming Investor Conferences
September 07, 2021 16:35 ET | EDAP TMS S.A.
LYON, France, September 7, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today announced that management will present at the following investor...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports Second Quarter 2021 Results and Provides Operational Update
August 25, 2021 16:35 ET | EDAP TMS S.A.
Total revenue for the first half 2021 of EUR 20.7 million (USD $24.8 million) increased 22.5% over the same period of the prior year Net income was EUR 0.4 million (USD 0.4 million), or EUR 0.01 per...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Select Preliminary Unaudited Second Quarter 2021 Results
August 04, 2021 08:00 ET | EDAP TMS S.A.
Total company second quarter 2021 revenue of approximately EUR 10.4 million (USD $12.4 million) increased 11.8% year-over-year; first half 2021 total company revenue of EUR 20.7 million (USD $24.8...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Issues Letter to Shareholders
July 20, 2021 08:00 ET | EDAP TMS S.A.
Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts LYON, France, July 20, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary
June 15, 2021 08:00 ET | EDAP TMS S.A.
Appointment brings highly experienced medical technology and commercialization leader to drive EDAP’s US expansion focus.Career accomplishments include 14 years at Intuitive Surgical, where he played...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports First Quarter 2021 Results and Provides Operational Update
May 11, 2021 16:30 ET | EDAP TMS S.A.
Generated record first quarter revenue of EUR 10.3 million (USD 12.4 million), an increase of 35.4% year-over-yearIncreased gross margin year-over-year to 42.4%, contributing to a profitable...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room
May 10, 2021 17:21 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...